一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Science >>article
Advanced Science

Advanced Science

IF: 14.3
Download PDF

HSPA8 Activates Wnt/β-Catenin Signaling to Facilitate BRAF V600E Colorectal Cancer Progression by CMA-Mediated CAV1 Degradation.

Published:16 November 2023 DOI: 10.1002/advs.202306535 PMID: 37973552
Bowen Li, Hui Ming, Siyuan Qin, Li Zhou, Zhao Huang, Ping Jin, Liyuan Peng, Maochao Luo, Tingting Zhang, Kui Wang, Rui Liu, Yih-Cherng Liou, Edouard C. Nice, Jingwen Jiang, Canhua Huang

Abstract

BRAF V600E attracts wide attention in the treatment of colorectal cancer (CRC) as stratifying and predicting a refractory classification of CRC. Recent evidence indicates that Wnt/β-catenin signaling is broadly activated and participates in the refractoriness of BRAF V600E CRC, but the underlying molecular mechanism needs to be elucidated. Here, heat shock 70 kDa protein 8 (HSPA8), an essential regulator in chaperone-mediated autophagy (CMA), is identified as a potential therapeutic target for advanced BRAF V600E CRC. These results show that HSPA8 is transcriptionally upregulated in BRAF V600E CRC, which promotes CMA-dependent degradation of caveolin-1 (CAV1) to release β-catenin into the nucleus and thus activates the Wnt/β-catenin pathway, contributing to metastasis and progression of BRAF V600E CRC. Of note, HSPA8 directly interacts with the KIFSN motif on CAV1, the interaction can be enhanced by p38 MAPK-mediated CAV1 S168 phosphorylation. Furthermore, pharmacological targeting HSPA8 by VER155008 exhibits synergistic effects with BRAF inhibitors on CRC mouse models. In summary, these findings discover the important role of the HSPA8/CAV1/β-catenin axis in the development of refractory BRAF V600E CRC and highlight HSPA8 as a predictive biomarker and therapeutic target in clinical practice.

Substances (4)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Encorafenib (LGX818) 1269440-17-6 C22H27ClFN7O4S 178 suppliers $37.00-$5210.50
Encorafenib (LGX818) 1269440-17-6 C22H27ClFN7O4S 178 suppliers $37.00-$5210.50
Encorafenib (LGX818) 1269440-17-6 C22H27ClFN7O4S 178 suppliers $37.00-$5210.50
Encorafenib (LGX818) 1269440-17-6 C22H27ClFN7O4S 178 suppliers $37.00-$5210.50

Similar articles

将乐县| 彭泽县| 荔波县| 墨玉县| 衡阳市| 九龙坡区| 乌拉特前旗| 同仁县| 莫力| 滨州市| 监利县| 桦川县| 江门市| 陵川县| 泌阳县| 昔阳县| 进贤县| 沁阳市| 贵州省| 丰台区| 土默特右旗| 军事| 河北区| 齐齐哈尔市| 山阳县| 定兴县| 宁海县| 浮山县| 勃利县| 张掖市| 临城县| 峨眉山市| 富川| 沂源县| 襄汾县| 西乡县| 信宜市| 垣曲县| 宁南县| 柏乡县| 沅陵县|